HALO logo

Halozyme Therapeutics, Inc. (HALO) Debt To Equity Ratio

Annual Debt To Equity:

4.14-13.75(-76.86%)
December 31, 2024

Summary

  • As of today, HALO annual debt to equity ratio is 4.14, with the most recent change of -13.75 (-76.86%) on December 31, 2024.
  • During the last 3 years, HALO annual debt to equity has fallen by -0.31 (-6.97%).
  • HALO annual debt to equity is now -76.86% below its all-time high of 17.89, reached on December 31, 2023.

Performance

HALO Debt To Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALOfinancial health metrics

Quarterly Debt To Equity:

4.54+1.41(+45.05%)
June 30, 2025

Summary

  • As of today, HALO quarterly debt to equity ratio is 4.54, with the most recent change of +1.41 (+45.05%) on June 30, 2025.
  • Over the past year, HALO quarterly debt to equity has dropped by -0.65 (-12.52%).
  • HALO quarterly debt to equity is now -79.99% below its all-time high of 22.69, reached on March 31, 2023.

Performance

HALO Quarterly Debt To Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALOfinancial health metrics

Debt To Equity Formula

Debt To Equity =  
Total Debt
Shareholders Equity

HALO Debt To Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-76.9%-12.5%
3Y3 Years-7.0%+6.8%
5Y5 Years-5.7%+23.0%

HALO Debt To Equity Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-76.9%at low-80.0%+45.0%
5Y5-Year-76.9%+57.4%-80.0%+72.6%
All-TimeAll-Time-76.9%+162.1%-80.0%+125.7%

HALO Debt To Equity History

DateAnnualQuarterly
Jun 2025
-
4.54(+45.0%)
Mar 2025
-
3.13(-24.4%)
Dec 2024
4.14(-76.9%)
4.14(+24.7%)
Sep 2024
-
3.32(-36.0%)
Jun 2024
-
5.19(-38.5%)
Mar 2024
-
8.44(-52.8%)
Dec 2023
17.89(+101.7%)
17.89(+197.7%)
Sep 2023
-
6.01(-39.4%)
Jun 2023
-
9.91(-56.3%)
Mar 2023
-
22.69(+155.8%)
Dec 2022
8.87(+99.3%)
8.87(-42.8%)
Sep 2022
-
15.51(+264.9%)
Jun 2022
-
4.25(+26.1%)
Mar 2022
-
3.37(-24.3%)
Dec 2021
4.45(+69.2%)
4.45(+43.1%)
Sep 2021
-
3.11(-57.4%)
Jun 2021
-
7.30(-43.5%)
Mar 2021
-
12.93(+391.6%)
Dec 2020
2.63(-40.1%)
2.63(-33.9%)
Sep 2020
-
3.98(+7.9%)
Jun 2020
-
3.69(-45.0%)
Mar 2020
-
6.71(+52.8%)
Dec 2019
4.39(+760.8%)
4.39(+1588.5%)
Sep 2019
-
0.26(-21.2%)
Jun 2019
-
0.33(-19.5%)
Mar 2019
-
0.41(-19.6%)
Dec 2018
0.51(-47.4%)
0.51(-16.4%)
Sep 2018
-
0.61(-6.2%)
Jun 2018
-
0.65(-7.1%)
Mar 2018
-
0.70(-27.8%)
Dec 2017
0.97(+114.5%)
0.97(-66.1%)
Sep 2017
-
2.86(-21.2%)
Jun 2017
-
3.63(+199.2%)
Mar 2017
-
-3.66(+45.1%)
Dec 2016
-6.67(-675.0%)
-6.67(+62.3%)
Sep 2016
-
-17.69(-184.3%)
Jun 2016
-
20.98(+215.5%)
Mar 2016
-
6.65(+473.3%)
Dec 2015
1.16(-4.1%)
1.16(-26.1%)
Sep 2015
-
1.57(+58.6%)
Jun 2015
-
0.99(-25.0%)
Mar 2015
-
1.32(+9.1%)
Dec 2014
1.21(+148.6%)
1.21(-3.2%)
Sep 2014
-
1.25(+38.9%)
Jun 2014
-
0.90(+20.0%)
Mar 2014
-
0.75(+130.1%)
Dec 2013
-2.49
-2.49(+70.8%)
DateAnnualQuarterly
Sep 2013
-
-8.53(-419.5%)
Jun 2013
-
2.67(+184.0%)
Mar 2013
-
0.94(+54.1%)
Dec 2012
0.61(>+9900.0%)
0.61(>+9900.0%)
Sep 2012
-
0.00(0.0%)
Jun 2012
-
0.00(0.0%)
Mar 2012
-
0.00(0.0%)
Dec 2011
0.00(0.0%)
0.00(0.0%)
Sep 2011
-
0.00(0.0%)
Jun 2011
-
0.00(0.0%)
Mar 2011
-
0.00(0.0%)
Dec 2010
0.00(0.0%)
0.00(0.0%)
Sep 2010
-
0.00(0.0%)
Jun 2010
-
0.00(0.0%)
Mar 2010
-
0.00(0.0%)
Dec 2009
0.00(0.0%)
0.00(0.0%)
Sep 2009
-
0.00(0.0%)
Jun 2009
-
0.00(0.0%)
Mar 2009
-
0.00(0.0%)
Dec 2008
0.00(0.0%)
0.00(0.0%)
Sep 2008
-
0.00(0.0%)
Jun 2008
-
0.00(0.0%)
Mar 2008
-
0.00(0.0%)
Dec 2007
0.00(0.0%)
0.00(0.0%)
Sep 2007
-
0.00(0.0%)
Jun 2007
-
0.00(0.0%)
Mar 2007
-
0.00(0.0%)
Dec 2006
0.00(0.0%)
0.00(0.0%)
Sep 2006
-
0.00(0.0%)
Jun 2006
-
0.00(0.0%)
Mar 2006
-
0.00(0.0%)
Dec 2005
0.00(0.0%)
0.00(0.0%)
Sep 2005
-
0.00(0.0%)
Jun 2005
-
0.00(0.0%)
Mar 2005
-
0.00(0.0%)
Dec 2004
0.00(0.0%)
0.00(0.0%)
Sep 2004
-
0.00(0.0%)
Jun 2004
-
0.00(0.0%)
Mar 2004
-
0.00(0.0%)
Dec 2003
0.00(0.0%)
0.00(0.0%)
Sep 2003
-
0.00(0.0%)
Jun 2003
-
0.00(0.0%)
Mar 2003
-
0.00(0.0%)
Dec 2002
0.00(0.0%)
0.00(0.0%)
Sep 2002
-
0.00(0.0%)
Jun 2002
-
0.00(0.0%)
Mar 2002
-
0.00
Dec 2001
0.00
-

FAQ

  • What is Halozyme Therapeutics, Inc. annual debt to equity ratio?
  • What is the all-time high annual debt to equity for Halozyme Therapeutics, Inc.?
  • What is Halozyme Therapeutics, Inc. annual debt to equity year-on-year change?
  • What is Halozyme Therapeutics, Inc. quarterly debt to equity ratio?
  • What is the all-time high quarterly debt to equity for Halozyme Therapeutics, Inc.?
  • What is Halozyme Therapeutics, Inc. quarterly debt to equity year-on-year change?

What is Halozyme Therapeutics, Inc. annual debt to equity ratio?

The current annual debt to equity of HALO is 4.14

What is the all-time high annual debt to equity for Halozyme Therapeutics, Inc.?

Halozyme Therapeutics, Inc. all-time high annual debt to equity ratio is 17.89

What is Halozyme Therapeutics, Inc. annual debt to equity year-on-year change?

Over the past year, HALO annual debt to equity ratio has changed by -13.75 (-76.86%)

What is Halozyme Therapeutics, Inc. quarterly debt to equity ratio?

The current quarterly debt to equity of HALO is 4.54

What is the all-time high quarterly debt to equity for Halozyme Therapeutics, Inc.?

Halozyme Therapeutics, Inc. all-time high quarterly debt to equity ratio is 22.69

What is Halozyme Therapeutics, Inc. quarterly debt to equity year-on-year change?

Over the past year, HALO quarterly debt to equity ratio has changed by -0.65 (-12.52%)
On this page